Moderna starts human trials for Bundibugyo Ebola vaccine as Congo's outbreak continues

Moderna has begun human trials for a Bundibugyo Ebola vaccine, Euronews reports, as the Democratic Republic of Congo battles its fastest-growing outbreak on record. The first participants have already been vaccinated. Bundibugyo is one of several Ebola virus strains, distinct from the more commonly studied Zaire species.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton